Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
- Cancer
- Concussions
- CRISPR
- Drug Pricing
- End of Life
- Health Disparities
- Immigration
- Opioids
- Trump
- Women’s Health
- Zika
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Reporting from the frontiers of health and medicine

In the Lab

How a teen’s skin cells, transformed into a beating model of a heart, have spurred research

By Rebecca Robbins

In the Lab

DEA solicited applications to grow marijuana for research. It hasn’t approved one

By Andrew Joseph

Hospitals

Support groups for ‘ICU survivors’ are springing up. But will patients traumatized by intensive care show up?

By Megan Thielking

Health Charlie Gard’s parents withdraw appeal to send baby to U.S. for treatment
Health Girl’s HIV infection seems under control without AIDS drugs
First Opinion Protecting interns and other physicians from depression and suicide
First Opinion A new wave of pharma mergers could put innovative drugs in the pipeline
Politics The drug industry is lobbying the federal government at a record-setting pace so far this year

Merck: Keytruda trial comes up short in head and neck cancer, but FDA approval stays
AbbVie must pay $150 million for misleading AndroGel marketing
With another White House delay, rule to bolster safety data on generic labels may be dead

advertisement

Follow Us

State of (Trump's) Mind

Trump’s New York Times interview is a window into his psyche

By Sharon Begley

Don't Miss

The 35 best health and science books to read this summer

Health

87 experimental therapies for glioblastoma are in the works. Some might help McCain now

By Sharon Begley

First Opinion

How much do doctors really make? Compare your salary to various specialties

By Zach Nayer

Special Report

Desperate for addiction treatment, patients are pawns in lucrative insurance fraud scheme

By David Armstrong — STAT and Evan Allen — Boston Globe

In the Lab

How a wildlife biologist became a plague-chaser in the American Southwest

By Eric Boodman

First Opinion A new wave of pharma mergers could put innovative drugs in the pipeline
Adam's Take Merck: Keytruda trial comes up short in head and neck cancer, but FDA approval stays
First Opinion Protecting interns and other physicians from depression and suicide
In the Lab DEA solicited applications to grow marijuana for research. It hasn’t approved one
Hospitals Support groups for ‘ICU survivors’ are springing up. But will patients traumatized by intensive care show up?

All Popular Stories

By Megan Thielking

Get ahead of the day's health and medicine news with our Morning Rounds newsletter.

Please enter a valid email address.

In the Lab

Turning your cancer against itself

By Sharon Begley

In the Lab

Researchers use CRISPR to store a movie in living bacteria

By Hyacinth Empinado

Science Happens!

Episode 6: This is what happens to DNA in space

Health

How George Washington’s teeth — from animals and maybe slaves — became an American legend

By Bob Tedeschi

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.

Sign up for our morning rounds newsletter

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT